Both atherosclerosis and autoimmune diseases are driven by inflammatory processes, and research has shown that proinflammatory cytokines such as tumor necrosis factor-alpha (TNFα) and interferon-gamma (IFNγ) can synergistically induce RNF213 expression, leading to angiogenesis in vitro and in vivo [56]. This evidence concerns the gene IFNG and autoimmune disease.